BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30883602)

  • 1. Breathlessness and incidence of COPD, cardiac events and all-cause mortality: A 44-year follow-up from middle age throughout life.
    Sandberg J; Engström G; Ekström M
    PLoS One; 2019; 14(3):e0214083. PubMed ID: 30883602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent disabling breathlessness in chronic obstructive pulmonary disease.
    Sundh J; Ekström M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2805-2812. PubMed ID: 27877034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.
    Verberkt CA; van den Beuken-van Everdingen MHJ; Schols JMGA; Hameleers N; Wouters EFM; Janssen DJA
    JAMA Intern Med; 2020 Oct; 180(10):1306-1314. PubMed ID: 32804188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Dyspnea Exertion Scale of Breathlessness in People With Life-Limiting Illness.
    Sandberg J; Johnson MJ; Currow DC; Ekström M
    J Pain Symptom Manage; 2018 Sep; 56(3):430-435.e2. PubMed ID: 29753099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.
    Casanova C; Marin JM; Martinez-Gonzalez C; de Lucas-Ramos P; Mir-Viladrich I; Cosio B; Peces-Barba G; Solanes-García I; Agüero R; Feu-Collado N; Calle-Rubio M; Alfageme I; de Diego-Damia A; Irigaray R; Marín M; Balcells E; Llunell A; Galdiz JB; Golpe R; Lacarcel C; Cabrera C; Marin A; Soriano JB; Lopez-Campos JL; Soler-Cataluña JJ; de-Torres JP;
    Chest; 2015 Jul; 148(1):159-168. PubMed ID: 25612228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of heart failure and chronic obstructive pulmonary disease on mortality in patients presenting with breathlessness.
    Cuthbert JJ; Kearsley JW; Kazmi S; Kallvikbakka-Bennett A; Weston J; Davis J; Rimmer S; Clark AL
    Clin Res Cardiol; 2019 Feb; 108(2):185-193. PubMed ID: 30091083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer.
    Volpino P; Cangemi R; Fiori E; Cangemi B; De Cesare A; Corsi N; Di Cello T; Cangemi V
    J Cardiovasc Surg (Torino); 2007 Jun; 48(3):375-83. PubMed ID: 17505444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.
    Rhee CK; Kim JW; Hwang YI; Lee JH; Jung KS; Lee MG; Yoo KH; Lee SH; Shin KC; Yoon HK
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1623-31. PubMed ID: 26316736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Modified Medical Research Council Dyspnea Scale for Predicting Hospitalization and Exacerbation in Japanese Patients with Chronic Obstructive Pulmonary Disease.
    Natori H; Kawayama T; Suetomo M; Kinoshita T; Matsuoka M; Matsunaga K; Okamoto M; Hoshino T
    Intern Med; 2016; 55(1):15-24. PubMed ID: 26726080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients.
    Cheng SL; Lin CH; Wang CC; Chan MC; Hsu JY; Hang LW; Perng DW; Yu CJ; Wang HC;
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):429-435. PubMed ID: 30150099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory symptoms and long-term risk of death from cardiovascular disease, cancer and other causes in Swedish men.
    Rosengren A; Wilhelmsen L
    Int J Epidemiol; 1998 Dec; 27(6):962-9. PubMed ID: 10024189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription of opioids for breathlessness in end-stage COPD: a national population-based study.
    Ahmadi Z; Bernelid E; Currow DC; Ekström M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2651-2657. PubMed ID: 27799763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study.
    Figarska SM; Boezen HM; Vonk JM
    Eur J Epidemiol; 2012 Nov; 27(11):867-76. PubMed ID: 23054033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of first-recorded breathlessness for future chronic respiratory and heart disease: a cohort study using a UK national primary care database.
    Chen Y; Hayward R; Chew-Graham CA; Hubbard R; Croft P; Sims K; Jordan KP
    Br J Gen Pract; 2020 Apr; 70(693):e264-e273. PubMed ID: 32041768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breathlessness, phlegm and mortality: 26 years of follow-up in healthy middle-aged Norwegian men.
    Stavem K; Sandvik L; Erikssen J
    J Intern Med; 2006 Oct; 260(4):332-42. PubMed ID: 16961670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which breathlessness dimensions associate most strongly with fatigue?-The population-based VASCOL study of elderly men.
    Cristea L; Olsson M; Sandberg J; Kochovska S; Currow D; Ekström M
    PLoS One; 2023; 18(12):e0296016. PubMed ID: 38117831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of NT-proBNP serum level in the diagnosis of dyspnea in COPD patients].
    Rubinsztajn R; Nasiłowski J; Przybyłowski T; Karwat K; Chazan R
    Pneumonol Alergol Pol; 2013; 81(1):24-9. PubMed ID: 23258468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study.
    Liang Y; Vetrano DL; Qiu C
    BMC Geriatr; 2017 Dec; 17(1):294. PubMed ID: 29281976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.
    Raparelli V; Pastori D; Pignataro SF; Vestri AR; Pignatelli P; Cangemi R; Proietti M; Davì G; Hiatt WR; Lip GYH; Corazza GR; Perticone F; Violi F; Basili S;
    Intern Emerg Med; 2018 Aug; 13(5):651-660. PubMed ID: 29582316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.